GlassScriptPhysician profile
Nyabilondi Ebama
NPI 1467618900
$2,577.34
in general payments reported to CMS, 2019-2025
16 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $262 · 2021: $312 · 2022: $727 · 2023: $632 · 2024: $122 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $925.15 | 2020-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $408.35 | 2019-2023 | |
| Theratechnologies INC. | $310.74 | 2019-2023 | Egrifta, Trogarzo |
| Merck Sharp & Dohme LLC | $303.75 | 2019-2023 | Delstrigo, Dificid, Pifeltro |
| Janssen Products, LP | $164.99 | 2019 | |
| Abbvie INC. | $100.46 | 2021-2022 | |
| Astellas Pharma US INC | $73.59 | 2022-2023 | Cresemba |
| Emd Serono, INC. | $69.40 | 2021-2023 | Serostim |
| Janssen Biotech, INC. | $55.57 | 2020-2022 | |
| Antares Pharma, INC. | $37.24 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Csl Behring | $36.90 | 2023 | Hizentra |
| Glaxosmithkline, LLC. | $25.88 | 2019 | |
| Insmed, INC. | $22.18 | 2021 | |
| Hologic Sales and Service, LLC | $16.58 | 2023 | Aptima |
| Novo Nordisk INC | $15.55 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nyabilondi Ebama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.